Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Q2 2024 Aytu Biopharma Inc Earnings Call Transcript

Feb 14, 2024 / 09:30PM GMT
Release Date Price: $3.21 (+11.28%)
Operator

Welcome to the Aytu Biopharma fiscal 2024 Q2 earnings call. At this time, all participants are in a listen only mode. (Operator Instructions) question and answer session will follow the formal presentation. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, [Roger Rice]. You may begin.

Roger Rice
- Moderator

Good afternoon, everyone, and thank you for joining us for Aytu Biopharma's fiscal 2024 second quarter financial and operational results. Conference call for the period ended December 31, 2023. Joining us on today's call is Aytu CEO, Josh Disbrow; and the Company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we'll open the call for a question and answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today.

Finally, I'd like to call your attention to the safe harbor disclosure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot